ABVC BioPharma Inc (ABVC)
1.08
-0.07
(-6.09%)
USD |
NASDAQ |
May 03, 16:00
1.13
+0.05
(+4.63%)
After-Hours: 20:00
ABVC BioPharma Profit Margin (Quarterly): -143.7K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -143.7K% |
September 30, 2023 | -20.89K% |
June 30, 2023 | -37.05K% |
March 31, 2023 | -1.42K% |
December 31, 2022 | -825.8% |
September 30, 2022 | -8.76K% |
June 30, 2022 | -594.2% |
March 31, 2022 | -23.36K% |
December 31, 2021 | |
September 30, 2021 | -1.82K% |
June 30, 2021 | -6.27K% |
March 31, 2021 | -428.8% |
December 31, 2020 | -7.80K% |
September 30, 2020 | -1.60K% |
June 30, 2020 | -816.4% |
March 31, 2020 | -1.58K% |
December 31, 2019 | -1.08K% |
September 30, 2019 | -614.4% |
June 30, 2019 | -290.7% |
March 31, 2019 | -373.0% |
December 31, 2018 | |
September 30, 2018 | -76.41K% |
June 30, 2018 | -19.58K% |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | -2.81K% |
June 30, 2015 | |
March 31, 2015 | 49.51% |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | -13.70K% |
December 31, 2012 | -2.19K% |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | -9.35K% |
December 31, 2011 | -13.53K% |
September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-143.7K%
Minimum
Dec 2023
-290.7%
Maximum
Jun 2019
-14.38K%
Average
-1.59K%
Median
Profit Margin (Quarterly) Benchmarks
NeuBase Therapeutics Inc | -- |
Sutro Biopharma Inc | 27.32% |
Reviva Pharmaceuticals Holdings Inc | -- |
Flora Growth Corp | -56.23% |
Journey Medical Corp | -14.05% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -241.2% |
Return on Assets | -86.59% |
Return on Invested Capital | -146.2% |
Gross Profit Margin (Quarterly) | -6.33K% |
Operating Margin (Quarterly) | -90.61K% |
Return on Net Operating Assets | -185.7% |